Inhibition of Depurinating Estrogen−DNA Adduct Formation by Natural Compounds
Authors:
- 27 November 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 20 (12) , 1947-1953
Abstract
Specific metabolites of estrogens, catechol estrogen-3,4-quinones, if produced in relatively large amounts, can become chemical carcinogens by reacting with DNA to form predominantly depurinating DNA adducts. Estradiol (E2)-3,4-quinone (Q) reacts with DNA to form predominantly the depurinating DNA adducts, 4-hydroxyestradiol (OHE2)-1-N3Ade and 4-OHE2-1-N7Gua. The depurinating adducts induce mutations by error-prone repair. We have conducted a study in which selected natural chemopreventing agents, N-acetylcysteine (NAcCys), melatonin, reduced lipoic acid, and resveratrol, have been tested for their ability to prevent the reaction of E2-3,4-Q with DNA. When DNA was incubated with E2-3,4-Q or lactoperoxidase-activated 4-OHE2 in the presence of an antioxidant, the formation of the N3Ade and N7Gua adducts was reduced. E2-3,4-Q or lactoperoxidase-oxidized 4-OHE2 (87 µM final concentration) was incubated with calf-thymus DNA and one of the antioxidants at different ratios (1:0, 1:0.3, 1:1, and 1:3 with respect to E2-3,4-Q or 4-OHE2) at 37 °C. After 10 h, the DNA was precipitated, and the supernatant was analyzed by using ultraperformance liquid chromatography/tandem mass spectrometry (LC/MS/MS). As anticipated, resveratrol and melatonin did not affect the formation of the depurinating adducts when E2-3,4-Q was reacted with DNA in their presence. On the other hand, NAcCys and lipoic acid (reduced form) showed a significant inhibition of the formation of the depurinating adducts by E2-3,4-Q. With reaction of lactoperoxidase-activated 4-OHE2 with DNA, resveratrol achieved the highest level of inhibition, NAcCys and reduced lipoic acid produced moderate inhibition, and melatonin had the least inhibition. These results demonstrate that all four selected compounds can inhibit the formation of depurinating estrogen−DNA adducts and set the stage for studies of their ability to inhibit adduct formation and malignant transformation in mammary epithelial cells. This approach is highly useful for identifying agents to prevent the initiation of human cancers, especially breast and prostate cancer.Keywords
This publication has 39 references indexed in Scilit:
- Formation of depurinating N3Adenine and N7Guanine adducts by MCF‐10F cells cultured in the presence of 4‐hydroxyestradiolInternational Journal of Cancer, 2007
- Potential biomarker for early risk assessment of prostate cancerThe Prostate, 2006
- The Greater Reactivity of Estradiol-3,4-quinone vs Estradiol-2,3-quinone with DNA in the Formation of Depurinating Adducts: Implications for Tumor-Initiating ActivityChemical Research in Toxicology, 2005
- Spectral Characterization of Catechol Estrogen Quinone (CEQ)-Derived DNA Adducts and Their Identification in Human Breast Tissue ExtractChemical Research in Toxicology, 2003
- Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancerCarcinogenesis, 2003
- Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancerCarcinogenesis, 2002
- Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumorsCarcinogenesis, 2001
- Imbalance of Estrogen Homeostasis in Kidney and Liver of Hamsters Treated with Estradiol: Implications for Estrogen-Induced Initiation of Renal TumorsChemical Research in Toxicology, 2001
- Functional role of estrogen metabolism in target cells: review and perspectivesCarcinogenesis, 1998
- Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiatorsProceedings of the National Academy of Sciences, 1997